GRI Bio Total Assets

GRI Bio (GRI) currently reports a total assets of $11M as of April 2026. That compares with $4M in the prior-year period — up 180.5% year over year. Use the charts on this page to explore GRI Bio's total assets history and peer comparisons.

GRI Bio's total assets increased from $4M to $11M — a 180.5% year-over-year increase (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GRI Bio reported $11M in total assets as of April 2026. That compares with $4M in the prior-year period — up 180.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GRI Bio, and consider following GRI for alerts when major investors trade the stock.

GRI Bio is classified in the Healthcare sector. On total assets, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GRI with unrelated industries.